company background image
524703 logo

Sandu Pharmaceuticals BSE:524703 Stock Report

Last Price

₹63.85

Market Cap

₹616.9m

7D

11.3%

1Y

12.1%

Updated

05 Apr, 2024

Data

Company Financials

Sandu Pharmaceuticals Limited

BSE:524703 Stock Report

Market Cap: ₹616.9m

Sandu Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sandu Pharmaceuticals
Historical stock prices
Current Share Price₹63.85
52 Week High₹85.00
52 Week Low₹49.00
Beta0.61
1 Month Change-2.95%
3 Month Change-11.11%
1 Year Change12.06%
3 Year Change89.75%
5 Year Change177.61%
Change since IPO751.33%

Recent News & Updates

Recent updates

Shareholder Returns

524703IN Personal ProductsIN Market
7D11.3%-0.7%3.2%
1Y12.1%0.8%48.9%

Rentabilidad frente al sector: 524703 superó al sector Indian Personal Products , que obtuvo un rendimiento del 3.5% el año pasado.

Rentabilidad vs. Mercado: 524703 obtuvo unos resultados inferiores a los del mercado Indian, que fue del 44.7% el año pasado.

Price Volatility

Is 524703's price volatile compared to industry and market?
524703 volatility
524703 Average Weekly Movement5.4%
Personal Products Industry Average Movement4.4%
Market Average Movement6.9%
10% most volatile stocks in IN Market10.3%
10% least volatile stocks in IN Market4.2%

Precio estable de las acciones: 524703 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 524703 (4%) se ha mantenido estable durante el año pasado.

About the Company

FoundedEmployeesCEOWebsite
1899323Umesh Sanduhttps://sandu.in

Sandu Pharmaceuticals Limited fabrica y comercializa medicamentos ayurvédicos bajo la marca SANDU en la India y a escala internacional. La empresa ofrece sandu mahasudarshan kadha no 1, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier y sandu vanari granules. También ofrece mahasudarshan kadha, amritarishta, tab.

Sandu Pharmaceuticals Limited Fundamentals Summary

How do Sandu Pharmaceuticals's earnings and revenue compare to its market cap?
524703 fundamental statistics
Market cap₹616.85m
Earnings (TTM)₹11.38m
Revenue (TTM)₹669.48m

54.2x

P/E Ratio

0.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524703 income statement (TTM)
Revenue₹669.48m
Cost of Revenue₹346.86m
Gross Profit₹322.62m
Other Expenses₹311.24m
Earnings₹11.38m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.18
Gross Margin48.19%
Net Profit Margin1.70%
Debt/Equity Ratio0%

How did 524703 perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

47%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.